Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: a ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-12

AUTHORS

M. T. Driessen, J. Whalen, B. Seewoodharry Buguth, L. A. Vallejo-Aparicio, I. P. Naya, Y. Asukai, B. Alcázar-Navarrete, M. Miravitlles, F. García-Río, N. A. Risebrough

ABSTRACT

BACKGROUND: A head-to-head study demonstrated the superiority of once-daily umeclidinium bromide/vilanterol (UMEC/VI) 62.5/25 mcg on trough forced expiratory volume in 1 s (FEV1) versus once-daily tiotropium/olodaterol (TIO/OLO) 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease (COPD). This analysis evaluated the cost effectiveness of UMEC/VI versus TIO/OLO from a Spanish National Healthcare System perspective, using data from this study and Spanish literature. METHODS: This analysis was conducted from the perspective of the Spanish National Healthcare System with a 3-year horizon as base case. A disease progression model using a linked risk equation approach was used to estimate disease progression and associated healthcare costs, and quality-adjusted life years (QALYs). The Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) study was used to develop the statistical risk equations for clinical endpoints, and costs were calculated using a health state approach (by dyspnea severity). Utilities for QALY calculation were estimated using patient baseline characteristics within a regression fit to Spanish observational data. Treatment effect, expressed as change from baseline in FEV1 was obtained from the head-to-head study and used in the model (UMEC/VI minus TIO/OLO difference: + 52 mL [95% confidence interval: 28, 77]). Baseline patient characteristics were sourced from Spanish literature or the head-to-head study if unavailable. A scenario analysis using only the intent-to-treat (ITT) population from the head-to-head study, and sensitivity analyses (including probabilistic sensitivity analyses), were conducted. Direct healthcare costs (2017 Euro) were obtained from Spanish sources and costs and benefits were discounted at 3% per annum. RESULTS: UMEC/VI was associated with small improvements in QALYs (+ 0.029) over a 3-year time horizon, compared with TIO/OLO, alongside cost savings of €393/patient. The ITT scenario analysis and sensitivity analyses had similar results. All probabilistic simulations resulted in UMEC/VI being less costly and more effective than TIO/OLO. CONCLUSION: UMEC/VI dominated TIO/OLO (more effective and less expensive). These results may aid payers and decision-makers in Spain when making judgements on which long-acting muscarinic antagonist/long-acting β2-agonist (LAMA/LABA) treatments can be considered cost effective in Spain. More... »

PAGES

224

References to SciGraph publications

  • 2017-11. Comparative Efficacy of Once-Daily Umeclidinium/Vilanterol and Tiotropium/Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: A Randomized Study in ADVANCES IN THERAPY
  • 2012-04. Cost Effectiveness of Pharmacological Maintenance Treatment for Chronic Obstructive Pulmonary Disease in PHARMACOECONOMICS
  • 2014-12. Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systems in HEALTH AND QUALITY OF LIFE OUTCOMES
  • 2016-12. A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices in PRIMARY CARE RESPIRATORY JOURNAL
  • 2017-12. Efficacy and safety of tiotropium and olodaterol in COPD: a systematic review and meta-analysis in RESPIRATORY RESEARCH
  • 2017-12. A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD in PULMONARY THERAPY
  • 2015-12. Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial in BMC PULMONARY MEDICINE
  • 2010-12. Characterisation of COPD heterogeneity in the ECLIPSE cohort in RESPIRATORY RESEARCH
  • 2010-10. Spanish recommendations on economic evaluation of health technologies in THE EUROPEAN JOURNAL OF HEALTH ECONOMICS
  • 2013-12. Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease in RESPIRATORY RESEARCH
  • 2016-12. The economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countries in BMC HEALTH SERVICES RESEARCH
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1186/s12931-018-0916-7

    DOI

    http://dx.doi.org/10.1186/s12931-018-0916-7

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1110046879

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/30458866


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0104", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Statistics", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/01", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Mathematical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Benzoxazines", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Benzyl Alcohols", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Chlorobenzenes", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cost-Benefit Analysis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cross-Over Studies", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Combinations", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "National Health Programs", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Prospective Studies", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Pulmonary Disease, Chronic Obstructive", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Quinuclidines", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Single-Blind Method", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Spain", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Tiotropium Bromide", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "GlaxoSmithKline (United Kingdom)", 
              "id": "https://www.grid.ac/institutes/grid.418236.a", 
              "name": [
                "Value Evidence and Outcomes, GSK, 980 Great West Road, TW8 9GS, Brentford, Middlesex, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Driessen", 
            "givenName": "M. T.", 
            "id": "sg:person.01355010313.69", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355010313.69"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "name": [
                "ICON Health Economics, ICON plc, Abingdon, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Whalen", 
            "givenName": "J.", 
            "id": "sg:person.012365335416.59", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012365335416.59"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "name": [
                "ICON Health Economics, ICON plc, Abingdon, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Seewoodharry Buguth", 
            "givenName": "B.", 
            "id": "sg:person.016215347516.38", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016215347516.38"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "GlaxoSmithKline (Spain)", 
              "id": "https://www.grid.ac/institutes/grid.419327.a", 
              "name": [
                "Departamento de Evaluaci\u00f3n de Medicamentos, GSK, Tres Cantos, Madrid, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Vallejo-Aparicio", 
            "givenName": "L. A.", 
            "id": "sg:person.01034450761.23", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034450761.23"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "GlaxoSmithKline (United Kingdom)", 
              "id": "https://www.grid.ac/institutes/grid.418236.a", 
              "name": [
                "Global Respiratory Franchise, GSK, Brentford, Middlesex, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Naya", 
            "givenName": "I. P.", 
            "id": "sg:person.010453460731.31", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010453460731.31"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "GlaxoSmithKline (United Kingdom)", 
              "id": "https://www.grid.ac/institutes/grid.418236.a", 
              "name": [
                "Value Evidence and Outcomes, GSK, 980 Great West Road, TW8 9GS, Brentford, Middlesex, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Asukai", 
            "givenName": "Y.", 
            "id": "sg:person.0667422360.61", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667422360.61"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "name": [
                "Hospital de Alta Resoluci\u00f3n de Loja, Granada, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Alc\u00e1zar-Navarrete", 
            "givenName": "B.", 
            "id": "sg:person.01276123024.24", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276123024.24"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Hospital Universitari Vall d'Hebron", 
              "id": "https://www.grid.ac/institutes/grid.411083.f", 
              "name": [
                "Pneumology Department, Hospital Universitari Vall d\u2019Hebron, Barcelona, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Miravitlles", 
            "givenName": "M.", 
            "id": "sg:person.0717175004.13", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717175004.13"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Hospital Universitario La Paz", 
              "id": "https://www.grid.ac/institutes/grid.81821.32", 
              "name": [
                "Hospital Universitario La Paz-IdiPAZ, Madrid, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Garc\u00eda-R\u00edo", 
            "givenName": "F.", 
            "id": "sg:person.0647036707.63", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647036707.63"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "name": [
                "ICON Health Economics, ICON, Toronto, ON, Canada"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Risebrough", 
            "givenName": "N. A.", 
            "id": "sg:person.01317033320.99", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317033320.99"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "https://doi.org/10.1016/s1579-2129(11)60005-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000319374"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.rmed.2013.06.001", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001828920"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s1579-2129(06)60198-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002071910"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1183/09031936.04.00014304", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002783277"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s12890-015-0092-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003319957", 
              "https://doi.org/10.1186/s12890-015-0092-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s12890-015-0092-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003319957", 
              "https://doi.org/10.1186/s12890-015-0092-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.rmed.2016.01.001", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003847006"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1164/rccm.200703-456so", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003862874"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2147/ceor.s116546", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1005467765"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.chest.2016.02.646", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1005507752"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0140-6736(09)61298-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1009754337"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/0272989x15610781", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010146834"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/0272989x15610781", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010146834"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.rmed.2014.10.002", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1011888243"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.arbres.2010.06.008", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013908107"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.rmed.2015.04.018", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015492289"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1136/thx.2009.115725", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015885352"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1136/thx.2009.115725", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015885352"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1124/pr.111.004580", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016840988"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/11589270-000000000-00000", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016970437", 
              "https://doi.org/10.2165/11589270-000000000-00000"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s12913-016-1482-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017525147", 
              "https://doi.org/10.1186/s12913-016-1482-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s12913-016-1482-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017525147", 
              "https://doi.org/10.1186/s12913-016-1482-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.jval.2010.09.011", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017740638"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2147/copd.s102962", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018309917"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.jval.2016.10.016", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018318934"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/0272989x16662009", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019326703"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/0272989x16662009", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019326703"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.arbr.2012.05.003", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021093523"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10198-010-0244-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021425920", 
              "https://doi.org/10.1007/s10198-010-0244-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1378/chest.125.1.249", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021989040"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/14651858.cd009285.pub2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024626911"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.arbres.2012.04.001", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1026046567"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1371/journal.pone.0089866", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1029826109"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2147/copd.s102494", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1030549045"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1465-9921-11-122", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035511693", 
              "https://doi.org/10.1186/1465-9921-11-122"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s2213-2600(14)70065-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037998562"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/npjpcrm.2016.79", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1040854561", 
              "https://doi.org/10.1038/npjpcrm.2016.79"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.jval.2014.08.1852", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041386772"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s12955-014-0120-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043272853", 
              "https://doi.org/10.1186/s12955-014-0120-5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s12955-014-0120-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043272853", 
              "https://doi.org/10.1186/s12955-014-0120-5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/0272989x16653118", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047284001"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/0272989x16653118", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047284001"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1378/chest.123.3.784", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047972268"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1378/chest.123.3.784", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047972268"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2147/copd.s94006", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1048170698"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2147/copd.s103335", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049076154"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1056/nejmoa0805800", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049406405"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1465-9921-14-49", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051849337", 
              "https://doi.org/10.1186/1465-9921-14-49"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/1753465814559209", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064075695"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/1753465814559209", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064075695"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2147/copd.s124482", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1074191215"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/14651858.cd012066.pub2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1083738889"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2147/copd.s119032", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1084386308"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2147/copd.s124420", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1084386315"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2147/copd.s131016", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1084815232"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.arbres.2017.03.018", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1085129170"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.arbr.2017.03.017", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1085442018"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2147/copd.s137872", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1091138880"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s41030-017-0048-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1091308147", 
              "https://doi.org/10.1007/s41030-017-0048-0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s41030-017-0048-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1091308147", 
              "https://doi.org/10.1007/s41030-017-0048-0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.jval.2017.08.1495", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1092327942"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12325-017-0626-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1092478443", 
              "https://doi.org/10.1007/s12325-017-0626-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s12931-017-0683-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1092982027", 
              "https://doi.org/10.1186/s12931-017-0683-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1183/1393003.congress-2017.pa2792", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1099874223"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1183/1393003.congress-2017.pa2792", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1099874223"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1183/1393003.congress-2017.pa2792", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1099874223"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2018-12", 
        "datePublishedReg": "2018-12-01", 
        "description": "BACKGROUND: A head-to-head study demonstrated the superiority of once-daily umeclidinium bromide/vilanterol (UMEC/VI) 62.5/25 mcg on trough forced expiratory volume in 1\u00a0s (FEV1) versus once-daily tiotropium/olodaterol (TIO/OLO) 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease (COPD). This analysis evaluated the cost effectiveness of UMEC/VI versus TIO/OLO from a Spanish National Healthcare System perspective, using data from this study and Spanish literature.\nMETHODS: This analysis was conducted from the perspective of the Spanish National Healthcare System with a 3-year horizon as base case. A disease progression model using a linked risk equation approach was used to estimate disease progression and associated healthcare costs, and quality-adjusted life years (QALYs). The Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) study was used to develop the statistical risk equations for clinical endpoints, and costs were calculated using a health state approach (by dyspnea severity). Utilities for QALY calculation were estimated using patient baseline characteristics within a regression fit to Spanish observational data. Treatment effect, expressed as change from baseline in FEV1 was obtained from the head-to-head study and used in the model (UMEC/VI minus TIO/OLO difference: +\u200952\u00a0mL [95% confidence interval: 28, 77]). Baseline patient characteristics were sourced from Spanish literature or the head-to-head study if unavailable. A scenario analysis using only the intent-to-treat (ITT) population from the head-to-head study, and sensitivity analyses (including probabilistic sensitivity analyses), were conducted. Direct healthcare costs (2017 Euro) were obtained from Spanish sources and costs and benefits were discounted at 3% per annum.\nRESULTS: UMEC/VI was associated with small improvements in QALYs (+\u20090.029) over a 3-year time horizon, compared with TIO/OLO, alongside cost savings of \u20ac393/patient. The ITT scenario analysis and sensitivity analyses had similar results. All probabilistic simulations resulted in UMEC/VI being less costly and more effective than TIO/OLO.\nCONCLUSION: UMEC/VI dominated TIO/OLO (more effective and less expensive). These results may aid payers and decision-makers in Spain when making judgements on which long-acting muscarinic antagonist/long-acting \u03b22-agonist (LAMA/LABA) treatments can be considered cost effective in Spain.", 
        "genre": "research_article", 
        "id": "sg:pub.10.1186/s12931-018-0916-7", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1028525", 
            "issn": [
              "1465-9921", 
              "1465-993X"
            ], 
            "name": "Respiratory Research", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "19"
          }
        ], 
        "name": "Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: a Spanish National Healthcare System perspective", 
        "pagination": "224", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "8da908d47a2575801957217f87f8c6681e5b5e4fda5fc3bbc08a1d62fc060f4d"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "30458866"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "101090633"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1186/s12931-018-0916-7"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1110046879"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1186/s12931-018-0916-7", 
          "https://app.dimensions.ai/details/publication/pub.1110046879"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-11T09:51", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000347_0000000347/records_89789_00000003.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://link.springer.com/10.1186%2Fs12931-018-0916-7"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12931-018-0916-7'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12931-018-0916-7'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12931-018-0916-7'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12931-018-0916-7'


     

    This table displays all metadata directly associated to this object as RDF triples.

    395 TRIPLES      21 PREDICATES      101 URIs      39 LITERALS      27 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1186/s12931-018-0916-7 schema:about N15e11e0eec0f4bc5aad25ffbc48dcaca
    2 N22e0c52269324ecf88383f2b3d2a9297
    3 N30b986d8ad904b2db9ceb6068fcc24e7
    4 N4d5b323e25514dfd999f373ad213c09e
    5 N58af184641744a54b366ffc36f6b2087
    6 N59685beddef1411297094b290f2b1cd7
    7 N682d5be99d1549cf96482c4d49f81135
    8 N6e29c6942c94484282f66c9b48d4e185
    9 N7859322abde341ce9db150fe1c3ed5a6
    10 N99f3a159e5134aa1814fad720558136e
    11 N9ce63262399b42bda8c6dd03dd6085be
    12 Nb78cf76afe174e78ae3712f927362f55
    13 Nc61463066e9e4949b5593c6c15299579
    14 Nc98a17c71a4c4743978c43f0f1649fff
    15 Ncef5f604a9d8419881cf24a380829341
    16 Ned7dc5bf0c354baea9a344cb0a31b271
    17 Nf89b2797ec5d4d5bac6768dfdd89e7ad
    18 Nfb3b47d055e4457ea08eb3afcac62696
    19 anzsrc-for:01
    20 anzsrc-for:0104
    21 schema:author N07241b958703405fbfb46b7c00baf0e3
    22 schema:citation sg:pub.10.1007/s10198-010-0244-4
    23 sg:pub.10.1007/s12325-017-0626-4
    24 sg:pub.10.1007/s41030-017-0048-0
    25 sg:pub.10.1038/npjpcrm.2016.79
    26 sg:pub.10.1186/1465-9921-11-122
    27 sg:pub.10.1186/1465-9921-14-49
    28 sg:pub.10.1186/s12890-015-0092-1
    29 sg:pub.10.1186/s12913-016-1482-7
    30 sg:pub.10.1186/s12931-017-0683-x
    31 sg:pub.10.1186/s12955-014-0120-5
    32 sg:pub.10.2165/11589270-000000000-00000
    33 https://doi.org/10.1002/14651858.cd009285.pub2
    34 https://doi.org/10.1002/14651858.cd012066.pub2
    35 https://doi.org/10.1016/j.arbr.2012.05.003
    36 https://doi.org/10.1016/j.arbr.2017.03.017
    37 https://doi.org/10.1016/j.arbres.2010.06.008
    38 https://doi.org/10.1016/j.arbres.2012.04.001
    39 https://doi.org/10.1016/j.arbres.2017.03.018
    40 https://doi.org/10.1016/j.chest.2016.02.646
    41 https://doi.org/10.1016/j.jval.2010.09.011
    42 https://doi.org/10.1016/j.jval.2014.08.1852
    43 https://doi.org/10.1016/j.jval.2016.10.016
    44 https://doi.org/10.1016/j.jval.2017.08.1495
    45 https://doi.org/10.1016/j.rmed.2013.06.001
    46 https://doi.org/10.1016/j.rmed.2014.10.002
    47 https://doi.org/10.1016/j.rmed.2015.04.018
    48 https://doi.org/10.1016/j.rmed.2016.01.001
    49 https://doi.org/10.1016/s0140-6736(09)61298-8
    50 https://doi.org/10.1016/s1579-2129(06)60198-5
    51 https://doi.org/10.1016/s1579-2129(11)60005-0
    52 https://doi.org/10.1016/s2213-2600(14)70065-7
    53 https://doi.org/10.1056/nejmoa0805800
    54 https://doi.org/10.1124/pr.111.004580
    55 https://doi.org/10.1136/thx.2009.115725
    56 https://doi.org/10.1164/rccm.200703-456so
    57 https://doi.org/10.1177/0272989x15610781
    58 https://doi.org/10.1177/0272989x16653118
    59 https://doi.org/10.1177/0272989x16662009
    60 https://doi.org/10.1177/1753465814559209
    61 https://doi.org/10.1183/09031936.04.00014304
    62 https://doi.org/10.1183/1393003.congress-2017.pa2792
    63 https://doi.org/10.1371/journal.pone.0089866
    64 https://doi.org/10.1378/chest.123.3.784
    65 https://doi.org/10.1378/chest.125.1.249
    66 https://doi.org/10.2147/ceor.s116546
    67 https://doi.org/10.2147/copd.s102494
    68 https://doi.org/10.2147/copd.s102962
    69 https://doi.org/10.2147/copd.s103335
    70 https://doi.org/10.2147/copd.s119032
    71 https://doi.org/10.2147/copd.s124420
    72 https://doi.org/10.2147/copd.s124482
    73 https://doi.org/10.2147/copd.s131016
    74 https://doi.org/10.2147/copd.s137872
    75 https://doi.org/10.2147/copd.s94006
    76 schema:datePublished 2018-12
    77 schema:datePublishedReg 2018-12-01
    78 schema:description BACKGROUND: A head-to-head study demonstrated the superiority of once-daily umeclidinium bromide/vilanterol (UMEC/VI) 62.5/25 mcg on trough forced expiratory volume in 1 s (FEV1) versus once-daily tiotropium/olodaterol (TIO/OLO) 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease (COPD). This analysis evaluated the cost effectiveness of UMEC/VI versus TIO/OLO from a Spanish National Healthcare System perspective, using data from this study and Spanish literature. METHODS: This analysis was conducted from the perspective of the Spanish National Healthcare System with a 3-year horizon as base case. A disease progression model using a linked risk equation approach was used to estimate disease progression and associated healthcare costs, and quality-adjusted life years (QALYs). The Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) study was used to develop the statistical risk equations for clinical endpoints, and costs were calculated using a health state approach (by dyspnea severity). Utilities for QALY calculation were estimated using patient baseline characteristics within a regression fit to Spanish observational data. Treatment effect, expressed as change from baseline in FEV1 was obtained from the head-to-head study and used in the model (UMEC/VI minus TIO/OLO difference: + 52 mL [95% confidence interval: 28, 77]). Baseline patient characteristics were sourced from Spanish literature or the head-to-head study if unavailable. A scenario analysis using only the intent-to-treat (ITT) population from the head-to-head study, and sensitivity analyses (including probabilistic sensitivity analyses), were conducted. Direct healthcare costs (2017 Euro) were obtained from Spanish sources and costs and benefits were discounted at 3% per annum. RESULTS: UMEC/VI was associated with small improvements in QALYs (+ 0.029) over a 3-year time horizon, compared with TIO/OLO, alongside cost savings of €393/patient. The ITT scenario analysis and sensitivity analyses had similar results. All probabilistic simulations resulted in UMEC/VI being less costly and more effective than TIO/OLO. CONCLUSION: UMEC/VI dominated TIO/OLO (more effective and less expensive). These results may aid payers and decision-makers in Spain when making judgements on which long-acting muscarinic antagonist/long-acting β2-agonist (LAMA/LABA) treatments can be considered cost effective in Spain.
    79 schema:genre research_article
    80 schema:inLanguage en
    81 schema:isAccessibleForFree true
    82 schema:isPartOf N3922b51896f540b99568aabdc62b8e8c
    83 N501ac5a38c0e4035823e2d27bc7cc287
    84 sg:journal.1028525
    85 schema:name Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: a Spanish National Healthcare System perspective
    86 schema:pagination 224
    87 schema:productId N1ff70df27b1a4583989bd4d7f8bcd580
    88 N7cb3493429da4c0c802fc83f5fca311c
    89 N9c6bcd301750462a8a47afdf42471f08
    90 Neeb97e75168d44a1a171024a95b1f1ba
    91 Nf14bfcb4bc374575a9f0c3ea1c564c21
    92 schema:sameAs https://app.dimensions.ai/details/publication/pub.1110046879
    93 https://doi.org/10.1186/s12931-018-0916-7
    94 schema:sdDatePublished 2019-04-11T09:51
    95 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    96 schema:sdPublisher N52ea92bb3a844f3f9cea423e71c5e8e6
    97 schema:url https://link.springer.com/10.1186%2Fs12931-018-0916-7
    98 sgo:license sg:explorer/license/
    99 sgo:sdDataset articles
    100 rdf:type schema:ScholarlyArticle
    101 N07241b958703405fbfb46b7c00baf0e3 rdf:first sg:person.01355010313.69
    102 rdf:rest N752e8353f4674f41a69bc17026cbc8a6
    103 N15e11e0eec0f4bc5aad25ffbc48dcaca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    104 schema:name Prospective Studies
    105 rdf:type schema:DefinedTerm
    106 N1ff70df27b1a4583989bd4d7f8bcd580 schema:name readcube_id
    107 schema:value 8da908d47a2575801957217f87f8c6681e5b5e4fda5fc3bbc08a1d62fc060f4d
    108 rdf:type schema:PropertyValue
    109 N22e0c52269324ecf88383f2b3d2a9297 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    110 schema:name Aged
    111 rdf:type schema:DefinedTerm
    112 N266277858ae6409f8981ecd4594d02fe schema:name Hospital de Alta Resolución de Loja, Granada, Spain
    113 rdf:type schema:Organization
    114 N2f762bdda1e14fb7bbbef99325c111af schema:name ICON Health Economics, ICON plc, Abingdon, UK
    115 rdf:type schema:Organization
    116 N30b986d8ad904b2db9ceb6068fcc24e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    117 schema:name Humans
    118 rdf:type schema:DefinedTerm
    119 N3922b51896f540b99568aabdc62b8e8c schema:volumeNumber 19
    120 rdf:type schema:PublicationVolume
    121 N4d5b323e25514dfd999f373ad213c09e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    122 schema:name National Health Programs
    123 rdf:type schema:DefinedTerm
    124 N501ac5a38c0e4035823e2d27bc7cc287 schema:issueNumber 1
    125 rdf:type schema:PublicationIssue
    126 N529332891c1d4923a742ede47047a216 rdf:first sg:person.010453460731.31
    127 rdf:rest Ndf43ac0477594eeeb3d8023d142b5bdc
    128 N52ea92bb3a844f3f9cea423e71c5e8e6 schema:name Springer Nature - SN SciGraph project
    129 rdf:type schema:Organization
    130 N54b9d31dcac74f43b268bc0e62cf05f6 schema:name ICON Health Economics, ICON, Toronto, ON, Canada
    131 rdf:type schema:Organization
    132 N58af184641744a54b366ffc36f6b2087 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    133 schema:name Spain
    134 rdf:type schema:DefinedTerm
    135 N59685beddef1411297094b290f2b1cd7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    136 schema:name Chlorobenzenes
    137 rdf:type schema:DefinedTerm
    138 N5e0d10a0087e4f708a58b96134f916ab schema:name ICON Health Economics, ICON plc, Abingdon, UK
    139 rdf:type schema:Organization
    140 N682d5be99d1549cf96482c4d49f81135 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    141 schema:name Benzoxazines
    142 rdf:type schema:DefinedTerm
    143 N6e29c6942c94484282f66c9b48d4e185 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    144 schema:name Quinuclidines
    145 rdf:type schema:DefinedTerm
    146 N752e8353f4674f41a69bc17026cbc8a6 rdf:first sg:person.012365335416.59
    147 rdf:rest N77f10fd3f1e24f62a560aa216b030129
    148 N77f10fd3f1e24f62a560aa216b030129 rdf:first sg:person.016215347516.38
    149 rdf:rest Nacf67a50243944a5acb5986e2756c073
    150 N7859322abde341ce9db150fe1c3ed5a6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    151 schema:name Pulmonary Disease, Chronic Obstructive
    152 rdf:type schema:DefinedTerm
    153 N7c1b7d3f790542049deebb2bc76cdbd7 rdf:first sg:person.0717175004.13
    154 rdf:rest N93ef51862dbf4a49a2ea59e9f76eead5
    155 N7cb3493429da4c0c802fc83f5fca311c schema:name pubmed_id
    156 schema:value 30458866
    157 rdf:type schema:PropertyValue
    158 N93ef51862dbf4a49a2ea59e9f76eead5 rdf:first sg:person.0647036707.63
    159 rdf:rest N97bd38ea0f7b4d1d8787dcc0f482278c
    160 N97bd38ea0f7b4d1d8787dcc0f482278c rdf:first sg:person.01317033320.99
    161 rdf:rest rdf:nil
    162 N99f3a159e5134aa1814fad720558136e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    163 schema:name Cost-Benefit Analysis
    164 rdf:type schema:DefinedTerm
    165 N9c6bcd301750462a8a47afdf42471f08 schema:name dimensions_id
    166 schema:value pub.1110046879
    167 rdf:type schema:PropertyValue
    168 N9ce63262399b42bda8c6dd03dd6085be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    169 schema:name Single-Blind Method
    170 rdf:type schema:DefinedTerm
    171 Nacf67a50243944a5acb5986e2756c073 rdf:first sg:person.01034450761.23
    172 rdf:rest N529332891c1d4923a742ede47047a216
    173 Nb78cf76afe174e78ae3712f927362f55 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    174 schema:name Female
    175 rdf:type schema:DefinedTerm
    176 Nc61463066e9e4949b5593c6c15299579 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    177 schema:name Benzyl Alcohols
    178 rdf:type schema:DefinedTerm
    179 Nc98a17c71a4c4743978c43f0f1649fff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    180 schema:name Middle Aged
    181 rdf:type schema:DefinedTerm
    182 Ncef5f604a9d8419881cf24a380829341 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    183 schema:name Drug Combinations
    184 rdf:type schema:DefinedTerm
    185 Ndf43ac0477594eeeb3d8023d142b5bdc rdf:first sg:person.0667422360.61
    186 rdf:rest Nf4c1aecb219a4d55a9af378589417dd8
    187 Ned7dc5bf0c354baea9a344cb0a31b271 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    188 schema:name Cross-Over Studies
    189 rdf:type schema:DefinedTerm
    190 Neeb97e75168d44a1a171024a95b1f1ba schema:name doi
    191 schema:value 10.1186/s12931-018-0916-7
    192 rdf:type schema:PropertyValue
    193 Nf14bfcb4bc374575a9f0c3ea1c564c21 schema:name nlm_unique_id
    194 schema:value 101090633
    195 rdf:type schema:PropertyValue
    196 Nf4c1aecb219a4d55a9af378589417dd8 rdf:first sg:person.01276123024.24
    197 rdf:rest N7c1b7d3f790542049deebb2bc76cdbd7
    198 Nf89b2797ec5d4d5bac6768dfdd89e7ad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    199 schema:name Tiotropium Bromide
    200 rdf:type schema:DefinedTerm
    201 Nfb3b47d055e4457ea08eb3afcac62696 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    202 schema:name Male
    203 rdf:type schema:DefinedTerm
    204 anzsrc-for:01 schema:inDefinedTermSet anzsrc-for:
    205 schema:name Mathematical Sciences
    206 rdf:type schema:DefinedTerm
    207 anzsrc-for:0104 schema:inDefinedTermSet anzsrc-for:
    208 schema:name Statistics
    209 rdf:type schema:DefinedTerm
    210 sg:journal.1028525 schema:issn 1465-9921
    211 1465-993X
    212 schema:name Respiratory Research
    213 rdf:type schema:Periodical
    214 sg:person.01034450761.23 schema:affiliation https://www.grid.ac/institutes/grid.419327.a
    215 schema:familyName Vallejo-Aparicio
    216 schema:givenName L. A.
    217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034450761.23
    218 rdf:type schema:Person
    219 sg:person.010453460731.31 schema:affiliation https://www.grid.ac/institutes/grid.418236.a
    220 schema:familyName Naya
    221 schema:givenName I. P.
    222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010453460731.31
    223 rdf:type schema:Person
    224 sg:person.012365335416.59 schema:affiliation N2f762bdda1e14fb7bbbef99325c111af
    225 schema:familyName Whalen
    226 schema:givenName J.
    227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012365335416.59
    228 rdf:type schema:Person
    229 sg:person.01276123024.24 schema:affiliation N266277858ae6409f8981ecd4594d02fe
    230 schema:familyName Alcázar-Navarrete
    231 schema:givenName B.
    232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276123024.24
    233 rdf:type schema:Person
    234 sg:person.01317033320.99 schema:affiliation N54b9d31dcac74f43b268bc0e62cf05f6
    235 schema:familyName Risebrough
    236 schema:givenName N. A.
    237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317033320.99
    238 rdf:type schema:Person
    239 sg:person.01355010313.69 schema:affiliation https://www.grid.ac/institutes/grid.418236.a
    240 schema:familyName Driessen
    241 schema:givenName M. T.
    242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355010313.69
    243 rdf:type schema:Person
    244 sg:person.016215347516.38 schema:affiliation N5e0d10a0087e4f708a58b96134f916ab
    245 schema:familyName Seewoodharry Buguth
    246 schema:givenName B.
    247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016215347516.38
    248 rdf:type schema:Person
    249 sg:person.0647036707.63 schema:affiliation https://www.grid.ac/institutes/grid.81821.32
    250 schema:familyName García-Río
    251 schema:givenName F.
    252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647036707.63
    253 rdf:type schema:Person
    254 sg:person.0667422360.61 schema:affiliation https://www.grid.ac/institutes/grid.418236.a
    255 schema:familyName Asukai
    256 schema:givenName Y.
    257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667422360.61
    258 rdf:type schema:Person
    259 sg:person.0717175004.13 schema:affiliation https://www.grid.ac/institutes/grid.411083.f
    260 schema:familyName Miravitlles
    261 schema:givenName M.
    262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717175004.13
    263 rdf:type schema:Person
    264 sg:pub.10.1007/s10198-010-0244-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021425920
    265 https://doi.org/10.1007/s10198-010-0244-4
    266 rdf:type schema:CreativeWork
    267 sg:pub.10.1007/s12325-017-0626-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092478443
    268 https://doi.org/10.1007/s12325-017-0626-4
    269 rdf:type schema:CreativeWork
    270 sg:pub.10.1007/s41030-017-0048-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091308147
    271 https://doi.org/10.1007/s41030-017-0048-0
    272 rdf:type schema:CreativeWork
    273 sg:pub.10.1038/npjpcrm.2016.79 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040854561
    274 https://doi.org/10.1038/npjpcrm.2016.79
    275 rdf:type schema:CreativeWork
    276 sg:pub.10.1186/1465-9921-11-122 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035511693
    277 https://doi.org/10.1186/1465-9921-11-122
    278 rdf:type schema:CreativeWork
    279 sg:pub.10.1186/1465-9921-14-49 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051849337
    280 https://doi.org/10.1186/1465-9921-14-49
    281 rdf:type schema:CreativeWork
    282 sg:pub.10.1186/s12890-015-0092-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003319957
    283 https://doi.org/10.1186/s12890-015-0092-1
    284 rdf:type schema:CreativeWork
    285 sg:pub.10.1186/s12913-016-1482-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017525147
    286 https://doi.org/10.1186/s12913-016-1482-7
    287 rdf:type schema:CreativeWork
    288 sg:pub.10.1186/s12931-017-0683-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1092982027
    289 https://doi.org/10.1186/s12931-017-0683-x
    290 rdf:type schema:CreativeWork
    291 sg:pub.10.1186/s12955-014-0120-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043272853
    292 https://doi.org/10.1186/s12955-014-0120-5
    293 rdf:type schema:CreativeWork
    294 sg:pub.10.2165/11589270-000000000-00000 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016970437
    295 https://doi.org/10.2165/11589270-000000000-00000
    296 rdf:type schema:CreativeWork
    297 https://doi.org/10.1002/14651858.cd009285.pub2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024626911
    298 rdf:type schema:CreativeWork
    299 https://doi.org/10.1002/14651858.cd012066.pub2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083738889
    300 rdf:type schema:CreativeWork
    301 https://doi.org/10.1016/j.arbr.2012.05.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021093523
    302 rdf:type schema:CreativeWork
    303 https://doi.org/10.1016/j.arbr.2017.03.017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085442018
    304 rdf:type schema:CreativeWork
    305 https://doi.org/10.1016/j.arbres.2010.06.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013908107
    306 rdf:type schema:CreativeWork
    307 https://doi.org/10.1016/j.arbres.2012.04.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026046567
    308 rdf:type schema:CreativeWork
    309 https://doi.org/10.1016/j.arbres.2017.03.018 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085129170
    310 rdf:type schema:CreativeWork
    311 https://doi.org/10.1016/j.chest.2016.02.646 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005507752
    312 rdf:type schema:CreativeWork
    313 https://doi.org/10.1016/j.jval.2010.09.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017740638
    314 rdf:type schema:CreativeWork
    315 https://doi.org/10.1016/j.jval.2014.08.1852 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041386772
    316 rdf:type schema:CreativeWork
    317 https://doi.org/10.1016/j.jval.2016.10.016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018318934
    318 rdf:type schema:CreativeWork
    319 https://doi.org/10.1016/j.jval.2017.08.1495 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092327942
    320 rdf:type schema:CreativeWork
    321 https://doi.org/10.1016/j.rmed.2013.06.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001828920
    322 rdf:type schema:CreativeWork
    323 https://doi.org/10.1016/j.rmed.2014.10.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011888243
    324 rdf:type schema:CreativeWork
    325 https://doi.org/10.1016/j.rmed.2015.04.018 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015492289
    326 rdf:type schema:CreativeWork
    327 https://doi.org/10.1016/j.rmed.2016.01.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003847006
    328 rdf:type schema:CreativeWork
    329 https://doi.org/10.1016/s0140-6736(09)61298-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009754337
    330 rdf:type schema:CreativeWork
    331 https://doi.org/10.1016/s1579-2129(06)60198-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002071910
    332 rdf:type schema:CreativeWork
    333 https://doi.org/10.1016/s1579-2129(11)60005-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000319374
    334 rdf:type schema:CreativeWork
    335 https://doi.org/10.1016/s2213-2600(14)70065-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037998562
    336 rdf:type schema:CreativeWork
    337 https://doi.org/10.1056/nejmoa0805800 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049406405
    338 rdf:type schema:CreativeWork
    339 https://doi.org/10.1124/pr.111.004580 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016840988
    340 rdf:type schema:CreativeWork
    341 https://doi.org/10.1136/thx.2009.115725 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015885352
    342 rdf:type schema:CreativeWork
    343 https://doi.org/10.1164/rccm.200703-456so schema:sameAs https://app.dimensions.ai/details/publication/pub.1003862874
    344 rdf:type schema:CreativeWork
    345 https://doi.org/10.1177/0272989x15610781 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010146834
    346 rdf:type schema:CreativeWork
    347 https://doi.org/10.1177/0272989x16653118 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047284001
    348 rdf:type schema:CreativeWork
    349 https://doi.org/10.1177/0272989x16662009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019326703
    350 rdf:type schema:CreativeWork
    351 https://doi.org/10.1177/1753465814559209 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064075695
    352 rdf:type schema:CreativeWork
    353 https://doi.org/10.1183/09031936.04.00014304 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002783277
    354 rdf:type schema:CreativeWork
    355 https://doi.org/10.1183/1393003.congress-2017.pa2792 schema:sameAs https://app.dimensions.ai/details/publication/pub.1099874223
    356 rdf:type schema:CreativeWork
    357 https://doi.org/10.1371/journal.pone.0089866 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029826109
    358 rdf:type schema:CreativeWork
    359 https://doi.org/10.1378/chest.123.3.784 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047972268
    360 rdf:type schema:CreativeWork
    361 https://doi.org/10.1378/chest.125.1.249 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021989040
    362 rdf:type schema:CreativeWork
    363 https://doi.org/10.2147/ceor.s116546 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005467765
    364 rdf:type schema:CreativeWork
    365 https://doi.org/10.2147/copd.s102494 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030549045
    366 rdf:type schema:CreativeWork
    367 https://doi.org/10.2147/copd.s102962 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018309917
    368 rdf:type schema:CreativeWork
    369 https://doi.org/10.2147/copd.s103335 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049076154
    370 rdf:type schema:CreativeWork
    371 https://doi.org/10.2147/copd.s119032 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084386308
    372 rdf:type schema:CreativeWork
    373 https://doi.org/10.2147/copd.s124420 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084386315
    374 rdf:type schema:CreativeWork
    375 https://doi.org/10.2147/copd.s124482 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074191215
    376 rdf:type schema:CreativeWork
    377 https://doi.org/10.2147/copd.s131016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084815232
    378 rdf:type schema:CreativeWork
    379 https://doi.org/10.2147/copd.s137872 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091138880
    380 rdf:type schema:CreativeWork
    381 https://doi.org/10.2147/copd.s94006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048170698
    382 rdf:type schema:CreativeWork
    383 https://www.grid.ac/institutes/grid.411083.f schema:alternateName Hospital Universitari Vall d'Hebron
    384 schema:name Pneumology Department, Hospital Universitari Vall d’Hebron, Barcelona, Spain
    385 rdf:type schema:Organization
    386 https://www.grid.ac/institutes/grid.418236.a schema:alternateName GlaxoSmithKline (United Kingdom)
    387 schema:name Global Respiratory Franchise, GSK, Brentford, Middlesex, UK
    388 Value Evidence and Outcomes, GSK, 980 Great West Road, TW8 9GS, Brentford, Middlesex, UK
    389 rdf:type schema:Organization
    390 https://www.grid.ac/institutes/grid.419327.a schema:alternateName GlaxoSmithKline (Spain)
    391 schema:name Departamento de Evaluación de Medicamentos, GSK, Tres Cantos, Madrid, Spain
    392 rdf:type schema:Organization
    393 https://www.grid.ac/institutes/grid.81821.32 schema:alternateName Hospital Universitario La Paz
    394 schema:name Hospital Universitario La Paz-IdiPAZ, Madrid, Spain
    395 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...